<DOC>
	<DOCNO>NCT01768351</DOCNO>
	<brief_summary>Current activate Vitamin D therapy approve treat secondary hyperparathyroidism chronic kidney disease ( CKD ) , large body experimental data animal confirm effect Vitamin D extend beyond mineral metabolism . Several study show benefit great new vitamin D analog paricalcitol compare calcitriol . A large gap exists knowledge epidemiological study human demonstrate improve outcome vitamin D use observation preclinical study demonstrate pleiotropic effect Vitamin D. To explore provenance epidemiological outcome CKD , conduct pilot randomize trial determine whether use paricalcitol , compare calcitriol , lead improvement anemia , marker associate bad outcome chronic kidney disease , whether effect reflect hyperparathyroidism correction , also dependent direct effect paricalcitol erythroid progenitor cell .</brief_summary>
	<brief_title>Paricalcitol Effect Anemia CKD</brief_title>
	<detailed_description>To good understand direct effect paricalcitol anemia patient chronic kidney disease ( stage 3-5 ) , conduct pilot trial 60 patient randomly allocate equally 2 group receive paricalcitol orally 6 month .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Inclusion criterion : age &gt; 18 write informed consent CKD stage 35 ( eGFR &lt; 60 ml/min/1,73 m2 ) PTH 30300 pg/ml Hb &lt; 10 g/dl &gt; 3 consecutive month Ferritin &gt; 100 ng/ml transferrin saturation ( TSAT ) 2040 % mean corpuscular volume ( MCV ) 8595 % patient treated Aceinhibitors angiotensin receptor blocker , dose stable &gt; 3 month patient treat erythropoiesisstimulating agent ( ESA ) , dose stable &gt; 3 month Exclusion criterion : anemia due non renal cause presence malignancy , inflammatory infectious disease &gt; 3 month pregnancy bleed &gt; 6 month Creactive protein ( CRP ) &gt; 1 mg/dl poorly control hypertension ( PAS &gt; 170 mmHG PAD &gt; 100 mmHg ) severe malnutrition hypercalcemia ( &gt; 10,5 mg/dl ) hyperphosphatemia ( &gt; 5,5 mg/dl ) surgical intervention &gt; 3 month acute myocardial infarction , unstable angina , stroke transitory ischemic attack , deep venous pulmonary thromboembolism , congestive heart failure &gt; 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>anemia</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>vitamin D</keyword>
	<keyword>paricalcitol</keyword>
	<keyword>hyperparathyroidism</keyword>
</DOC>